Anakinra for the Treatment of Antisynthetase Syndrome: A Monocentric Case Series and a Systematic Literature Review.
Campochiaro CorradoNicola FarinaGiacomo DE LucaGiorgia TrignaniAlessandro TomelleriMarco Matucci-CerinicLorenzo DagnaPublished in: The Journal of rheumatology (2022)
Antisynthetase syndrome (AS) is a rare autoimmune disorder whose treatment remains a challenge. 1 In refractory cases, treatment escalation from glucocorticoids (GCs) and immunosuppressants to rituximab (RTX) is recommended. 1 .